Your browser doesn't support javascript.
loading
Genetic Inhibition of APOL1 Pore-Forming Function Prevents APOL1-Mediated Kidney Disease.
Hung, Adriana M; Assimon, Victoria A; Chen, Hua-Chang; Yu, Zhihong; Vlasschaert, Caitlyn; Triozzi, Jefferson L; Chan, Helen; Wheless, Lee; Wilson, Otis; Shah, Shailja C; Mack, Taralynn; Thompson, Trevor; Matheny, Michael E; Chandrasekar, Saranya; Mozaffari, Sahar V; Chung, Cecilia P; Tsao, Philip; Susztak, Katalin; Siew, Edward D; Estrada, Karol; Gaziano, J Michael; Graham, Robert R; Tao, Ran; Hoek, Maarten; Robinson-Cohen, Cassianne; Green, Eric M; Bick, Alexander G.
Afiliación
  • Hung AM; Nashville VA Medical Center, VA Tennessee Valley Healthcare System, Nashville, Tennessee.
  • Assimon VA; Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Chen HC; Maze Therapeutics, South San Francisco, California.
  • Yu Z; Nashville VA Medical Center, VA Tennessee Valley Healthcare System, Nashville, Tennessee.
  • Vlasschaert C; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Triozzi JL; Nashville VA Medical Center, VA Tennessee Valley Healthcare System, Nashville, Tennessee.
  • Chan H; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Wheless L; Department of Medicine, Queen's University, Kingston, Ontario, Canada.
  • Wilson O; Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Shah SC; Maze Therapeutics, South San Francisco, California.
  • Mack T; Department of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Thompson T; Nashville VA Medical Center, VA Tennessee Valley Healthcare System, Nashville, Tennessee.
  • Matheny ME; Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Chandrasekar S; VA San Diego Healthcare System and UC San Diego Health, La Jolla, California.
  • Mozaffari SV; Nashville VA Medical Center, VA Tennessee Valley Healthcare System, Nashville, Tennessee.
  • Chung CP; Division of Genetic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Tsao P; Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Susztak K; Nashville VA Medical Center, VA Tennessee Valley Healthcare System, Nashville, Tennessee.
  • Siew ED; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Estrada K; Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Gaziano JM; Maze Therapeutics, South San Francisco, California.
  • Graham RR; Maze Therapeutics, South San Francisco, California.
  • Tao R; Department of Rheumatology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Hoek M; VA Palo Alto Health Care System, Palo Alto, California.
  • Robinson-Cohen C; Department of Medicine, Stanford University School of Medicine, Stanford, California.
  • Green EM; Renal, Electrolyte, and Hypertension Division, Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania.
  • Bick AG; Nashville VA Medical Center, VA Tennessee Valley Healthcare System, Nashville, Tennessee.
J Am Soc Nephrol ; 34(11): 1889-1899, 2023 11 01.
Article en En | MEDLINE | ID: mdl-37798822
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Insuficiencia Renal Crónica / Apolipoproteína L1 / Salud Poblacional Tipo de estudio: Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: J Am Soc Nephrol Asunto de la revista: NEFROLOGIA Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Insuficiencia Renal Crónica / Apolipoproteína L1 / Salud Poblacional Tipo de estudio: Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: J Am Soc Nephrol Asunto de la revista: NEFROLOGIA Año: 2023 Tipo del documento: Article